The effects of Nocturnal Haemodialysis (NHD) compared to conventional haemodialysis on progression of Left Ventricular (LV) mass: a randomised controlled pilot study
| ISRCTN | ISRCTN25858715 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN25858715 |
| Protocol serial number | N/A |
| Sponsor | Kidney Foundation of Canada (Canada) |
| Funder | Kidney Foundation of Canada (Canada) |
- Submission date
- 08/09/2004
- Registration date
- 19/10/2004
- Last edited
- 20/09/2007
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Urological and Genital Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Bruce Culleton
Scientific
Scientific
Foothills Hospital
1403-29th ST NW
Calgary
T2N 2T9
Canada
| Phone | +1 403 944 8166 |
|---|---|
| bruce.culleton@calgaryhealthregion.ca |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Scientific title | |
| Study objectives | Nocturnal haemodialysis and conventional three times per week haemodialysis will not differ with respect to progression of LV mass (measured using Cardiac Magnetic Resonance [CMR]) at 6 months. |
| Ethics approval(s) | Not provided at time of registration. |
| Health condition(s) or problem(s) studied | End-stage kidney disease |
| Intervention | Subjects are randomised to nocturnal haemodialysis or conventional three times per week haemodialysis (controls). |
| Intervention type | Other |
| Primary outcome measure(s) |
Change in left ventricular mass (measured by CMR) at 6 months. |
| Key secondary outcome measure(s) |
1. Mean change in systolic Blood Pressure (BP) |
| Completion date | 30/06/2006 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | |
| Target sample size at registration | 38 |
| Key inclusion criteria | All adult haemodialysis patients in Alberta, Canada are eligible. |
| Key exclusion criteria | Patients who are unable to perform NHD due to physical or mental incapacity. |
| Date of first enrolment | 01/08/2004 |
| Date of final enrolment | 30/06/2006 |
Locations
Countries of recruitment
- Canada
Study participating centre
Foothills Hospital
Calgary
T2N 2T9
Canada
T2N 2T9
Canada
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | Results | 19/09/2007 | Yes | No |
